🇺🇸 FDA
Patent

US 11147782

GHB formulation and method for its manufacture

granted A61KA61K31/19A61K31/785

Quick answer

US patent 11147782 (GHB formulation and method for its manufacture) held by Jazz Pharmaceuticals Ireland Limited expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jazz Pharmaceuticals Ireland Limited
Grant date
Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/19, A61K31/785, A61K38/02, A61K9/10